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Purpose:  Bone tissues for clinical application can be improved by studies on osteoblast differentiation. Runx2 is known to be 
an important transcription factor for osteoblast differentiation. However, bone morphogenetic protein (BMP)-2 treatment to 
stimulate Runx2 is not sufficient to acquire enough bone formation in osteoblasts. Therefore, it is necessary to find other reg-
ulatory factors which can improve the transcriptional activity of Runx2. The erythroblast transformation-specific (ETS) tran-
scription factor family is reported to be involved in various aspects of cellular proliferation and differentiation.
Methods:  We have noticed that the promoters of osteoblast differentiation markers such as alkaline phosphatase (Alp), osteo-
pontin (Opn), and osteocalcin (Oc) contain Ets binding sequences which are also close to Runx2 binding elements. Luciferase 
assays were performed to measure the promoter activities of these osteoblast differentiation markers after the transfection of 
Runx2, myeloid Elf-1-like factor (MEF), and Runxs+MEF. Reverse-transcription polymerase chain reaction was also done to check 
the mRNA levels of Opn after Runx2 and MEF transfection into rat osteoblast (ROS) cells.
Results:  We have found that MEF, an Ets transcription factor, increased the transcriptional activities of Alp, Opn, and Oc. The 
addition of Runx2 resulted in the 2- to 6-fold increase of the activities. This means that these two transcription factors have a 
synergistic effect on the osteoblast differentiation markers. Furthermore, early introduction of these two Runx2 and MEF fac-
tors significantly elevated the expression of the Opn mRNA levels in ROS cells. We also showed that Runx2 and MEF proteins 
physically interact with each other.
Conclusions:  Runx2 interacts with MEF proteins and binds to the promoters of the osteoblast markers such as Opn nearby 
MEF to increase its transcriptional activity. Our results also imply that osteoblast differentiation and bone formation can be 
increased by activating MEF to elicit the synergistic effect of Runx2 and MEF.
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INTRODUCTION
Bone remodeling is a response process to the functional 
demands of mechanical loading, and controls the reshaping 
or replacement of bone during growth and microfractures 
that occur during normal activity. The equilibrium between 
bone formation by osteoblasts and bone resorption by osteo-
clasts maintains a stable level of bone mass [1-8]. As far as the 
regulation of bone remodeling is concerned, many factors 
exist. The regulation of bone remodeling is accomplished by 
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both systemic and local processes.
A transcription factor is a protein that binds to specific DNA 
sequences and thereby controls the transcription of genetic 
information from DNA to mRNA. It functions alone or with 
other proteins in a complex by promoting or blocking the re-
cruitment of the RNA polymerase to the specific genes. In 
bone remodeling, many transcription factors such as Runx2 
and osterix are known to be involved, and the deficiency or 
overexpression of some of these factors generates severe met-
abolic disorders in bone [1,9-12].
The erythroblast transformation-specific (ETS) families of 
transcription factors control the expression of genes that are 
critical for cell proliferation, differentiation, and cell death. 
Some ETS transcription factors are also known to regulate 
bone development [13]. ETS-1, the founding member of the 
ETS family, which was originally from avian E26 retrovirus, is 
reported to be expressed in proliferating preosteoblastic cells, 
whereas ETS-2 is expressed in the differentiated and mature 
osteoblasts [13].
Myeloid Elf-1-like factor (MEF) was originally isolated from 
a human megakaryocytic leukemia cell line [14]. MEF con-
tains a central ETS DNA binding domain and is expressed in 
a variety of myeloid leukemia cell lines and in normal adult 
hematopoietic tissues as well as in non-hematopoietic tis-
sues [14]. MEF is a member of the Elf-1/E74 family of ETS pro-
teins and has DNA binding properties similar to those of Elf-
1. Eighty of the 85 amino acids in the ETS domain are identi-
cal in the MEF and Elf-1 proteins [15]. It has been reported that 
MEF transcriptionally activates genes expressed in lymphoid, 
myeloid, and epithelial cells, such as interleukin-8 and human 
beta-defensin 2 [16,17].
In this study, we analyzed the transcriptional function of 
MEF in the bone marker genes, osteopontin (Opn), osteocal-
cin (Oc), and alkaline phosphatase (Alp). Also, since these pro-
moters have Runx binding sites close to potential ETS bind-
ing sites, we have hypothesized that MEF and Runx2 might 
have functional cooperativity on these promoters. This study 
provides a novel insight into the role of MEF transcription 
factor in osteogenesis.
MATERIALS AND METHODS
Materials
Fetal bovine sera were from GIBCO-BRL (Invitrogen Co., 
Carlsbad, USA). The RevertAIDTM strand cDNA synthesis kit 
for reverse transcription was from Fermentas (Vilnius, Lithu-
ania). Lipofectamin Plus was from Invitrogen (Carlsbad, USA) 
and Taq polymerase, the dNTP mixture and G418 were from 
Promega (Madison, USA).
DNA polymerase was from Invitrogen, Taq polymerase and 
the dNTP mixture were from Progmega.
Cell culture
Rat osteoblast ROS17/2.8 cells from a rat osteosarcoma were 
maintained in a-MEM. The cell maintenance protocol and 
the culture conditions used were as previously described [18]. 
COS7 cells were maintained in DMEM/high glucose (Hy-
clone, Logan, USA) with 10% FBS and 1% antibiotic-antimy-
cotic. Lipofectamine Plus reagent was used for the transfec-
tion of the ROS17/2.8 and COS7 cells according to the manu-
facturer’s protocol.
DNA construction
The plasmid containing Runx2 was constructed by cloning 
a Runx2 cDNA into the BamH I and Xho I sites of pcDNA3.1-
FLAG or the Hind III and Xho I sites of pcDNA3.1-Myc. MEF 
was cloned into the BamH I and Xho I sites of pcDNA3.1-
FLAG. The mouse Alp promoter (-1838 bp) in the pGL3 basic 
vector was kindly provided by Harada et al. [19] Oc promoter 
(1050-luciferase) was from Towler et al. [20,21]. The Opn pro-
moter (1983 bp) was amplified by nested polymerase chain 
reaction (PCR) from mouse genomic DNA. The resulting frag-
ment was ligated into the XhoI and HindIII sites of the pGL2-
Basic firefly luciferase reporter vector (Promega).
Transient transfection and luciferase assay
The day before transfection, COS7 cells were plated on 6- 
well plates at a density of 1.2 × 10
5 cells/well. The cells were 
transfected with Lipofectamine Plus reagent (Invitrogen Co., 
Carlsbad, USA) according to the manufacturer’s protocol. Each 
transfection for luciferase assay was performed with the same 
amount of ETS cDNA (in pCDNA3.1-Flag), Runx2 + CBFbeta 
cDNA, or pcDNA3.1 (Mock) and the Opn, Oc, or Alp gene pro-
moters-luciferase reporters. Total DNA of 0.5 µg per well was 
used in each transfection for the luciferase assay. Twenty four 
hours after transfection, the cells were harvested for the lu-
ciferase assay. The supernatants from cell lysates were used 
for the luciferase assay system (Promega Co., Madison, USA). 
The results presented are representative data from at least 
two independent experiments with triplicate wells in each 
experiment.
Determination of mRNA levels
Total cellular RNA was extracted from cells using TRIzol re-
agent and its concentration was measured by spectrophotom-
etry. Total RNA was reverse-transcribed to produce cDNA 
using the Fermentas reverse transcription kit, according to 
the manufacturer’s protocol. For reverse-transcription PCR 
(RT-PCR) analysis, mouse GAPDH specific primers were used 
as previously described [18]. To determine the Opn mRNA Journal of Periodontal
& Implant Science JPIS
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levels, RT-PCR was performed using the following primers: 
Opn forward 5’-TTCACAGCCACAAGGACAAG-3’, Opn re-
verse 5’-TTACAACGGTGTTTGCATGA-3’.
Statistical analysis
Each luciferase assay and real-time PCR experiment was 
done in triplicate. Numerical data from representative inves-
tigations are expressed as mean ± SEM. The significance of 
the differences was determined using two-tailed Student’s t-
tests. A value of P < 0.05 was considered to indicate a signifi-
cant difference.
RESULTS
Promoter sequence analysis showed ETS responsive element 
close to Runx responsive element in Opn, Oc, and Alp
We first investigated whether the promoters of the bone 
marker genes Opn, Oc, and Alp have an ETS responsive ele-
ment (ERE) and Runx responsive element (RRE). More im-
portantly, we focused on whether ERE and RRE are present 
close by each other, with about a 10.5 base pair distance, be-
cause the double helix DNA 1 turn is 10.5 base pairs and if the 
binding sites are this distance and multiples of this distance 
close by, it strongly suggests that the two transcription fac-
tors have a synergistic effect in their transactivity as long as 
the two proteins also have binding affinities. It is well known 
that Runx1 and MEF proteins have protein-protein interac-
tions [22].
In Opn promoter, ETS responsive elements were observed 
in the -347 to -338 and -213 to -208 regions. RRE was found 
from -229 to -223 (Fig. 1A). Second ERE had a distance span-
ning from 10 to 21 base pairs with the RRE sites. This obser-
vation strongly suggests the cooperativity of the Runx and 
Ets proteins in this Opn promoter. In Oc promoter, Runx re-
sponsive elements were observed in the -634 to -629 and -599 
to -594 regions. ERE was found in -576 to -563 (Fig. 2A). Sec-
ond RRE had a distance spanning from 18 to 36 base pairs 
from the RRE sites. This observation also strongly suggests 
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Figure 1.  Synergistic effects of erythroblast transformation-specific 
(ETS) and Runx2 on the osteopontin (Opn) promoter. (A) Sequence 
analysis of the Opn promoter showed potential ETS and Runx2 bind-
ing elements. (B) Opn-luciferase (Opn-Luc) promoter construct (1,983 
bp) was co transfected with ETS transcription factors as designated 
with or without Runx2 + CBFbeta into COS7 cells. Twenty-four hours 
after transfection the luciferase activity was measured as described 
in the Materials and Methods. In the Opn-Luc graph, the black bar 
is for only pCDNA3.1 vector and the gray bar is for Runx2 + CBFbeta 
as expression cDNA.
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Figure 2.  Synergistic effects of erythroblast transformation-specific 
(ETS) and Runx2 on the osteocalcin (Oc) promoter. (A) Sequence anal-
ysis of the Oc promoter showed potential ETS and Runx2 response 
elements. (B) Oc-luciferase (Oc-Luc) promoter construct (1,080 bp) 
was co-transfected with ETS transcription factors as designated with 
or without Runx2 + CBFbeta into COS7 cells. Twenty-four hours after 
transfection, the luciferase activity was measured. In Oc-Luc graph, 
the black bar is for pCDNA3.1 vector only and the grey bar is for Runx2 
+ CBFbeta as expression cDNA.Journal of Periodontal
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the cooperativity of the Runx and Ets proteins in this Oc pro-
moter. In the Alp promoter, ETS responsive elements were 
found in the -1,140 to -1,130 and -701 to -689 regions. RRE 
was found in the -1,115 to -1,109 and -716 to -710 regions (Fig. 
3A). The first ERE and first RRE exist at a distance of 15 to 31 
base pairs from each other, and the second RRE and second 
ERE at 9 to 27 base pairs from each other. This observation 
also strongly suggests there are two cooperativities of the 
Runx and ETS proteins in the Alp promoter. However, in the 
bone sialoprotein (BSP) promoter, we could not find any RRE 
and ERE close by in the proximal promoter region.
MEF and Runx2 had synergistic transactivity on the Opn, Oc, 
and Alp promoters
We then tested whether the bone marker gene promoters 
respond to MEF and Runx2, and whether they show any func-
tional cooperativities in the transactivating powers on these 
promoters. Cos7 cells were transfected with each luciferase 
construct and MEF cDNA with Runx2 +CBFbeta cDNA con-
structs.
In the Opn-luciferase (Opn-Luc) assay, we found that among 
the ETS transcription factors tested, MEF showed the highest 
luciferase activity (Fig. 1B). Furthermore, when Runx2 + CBF-
beta was added, the activity was increased 4.5-fold, although 
this Opn promoter showed minimal transactivity to only 
Runx2 + CBFbeta transfection. Thus, MEF and Runx2 co-trans-
fection resulted in a significant synergistic effect on the Opn-
Luc promoter activity. In the Oc-luciferase assay, we found 
that among ETS transcription factors tested, ETV-1, ETS-2, 
and MEF showed high luciferase activity (Fig. 2B). Although 
EVT-1 and ETS-2 showed high transactivities on the Oc pro-
moter, it did not show any further increase of the promoter 
activities upon Runx2 + CBFbeta addition. However, in MEF 
transfection, Runx2 + CBFbeta addition resulted in about a 
2-fold increase, which is more than the additive amount of 
Runx2 + CBFbeta (grey bar in Oc-Luc graph) and MEF. Thus, 
MEF and Runx2 co-transfection also showed a significant 
synergistic effect on Oc-Luc promoter activity. In the Alp-lu-
ciferase assay, we found that Runx2 + CBFbeta cDNA trans-
fection only resulted in relative luciferase activity (RLA) of 
about 20,000. MEF transfection showed an RLA of about 
40,000. However, co-transfection of the expression vectors 
MEF and Runx2 + CBFbeta resulted in an RLA of 100,000 (Fig. 
3B). Again, with the Alp promoter, MEF and Runx2 co-trans-
fection had a significant synergistic effect on Alp-Luc pro-
moter activity. However, in the BSP promoter, co-transfec-
tion of Runx2 + CBFbeta with ETS did not show any synergis-
tic effect (Figs. 4A and B). This coincides well with the obser-
vation that there are no sequences with ERE and RRE close 
by in the proximal region of the BSP promoter.
MEF and Runx2 co-transfection showed higher Opn mRNA 
expression in ROS cells
We then tested whether MEF can induce endogenous Opn 
expression at early treatment of MEF (24 hours after transfec-
tion). ROS17/2.8 rat osteosarcoma cells were transfected with 
Figure 3.  Synergistic effects of erythroblast transformation-specific (ETS) and Runx2 on the alkaline phosphatase (Alp) promoter. (A) Sequence 
analysis of the Alp promoter showed potential ETS and Runx2 binding elements. (B) Alp-luciferase (Alp-Luc) promoter construct (1.9 kb) was 
co-transfected with myeloid Elf-1-like factor (MEF) transcription factor with or without Runx2 + CBFbeta into COS7 cells. Twenty-four hours 
after transfection the luciferase activity was measured. In the Alp-Luc graph, the black bar is for pCDNA3.1 vector only and the grey bar is for 
Runx2 + CBFbeta as expression cDNA.
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Mef cDNA alone, Runx2+CBFbeta cDNA, or MEF together 
with Runx2 + CBFbeta. MEF transfection resulted in higher 
Opn mRNA expression than Runx2+CBFbeta transfection. 
When the cells were transfected with MEF and Runx2 + CBF-
beta together, the Opn mRNA expression was highly increased, 
suggesting again that MEF and Runx2 proteins might have a 
synergistic effect on Opn gene expression.
DISCUSSION
Our data showed that for the synergistic effect of MEF with 
Runx2 on the bone marker gene promoters, it required those 
two transcription factor responsive elements (RRE and ERE) 
existing close by on the proximal regions of the promoters. 
Thus, those promoters such as Opn, Oc, and Alp, having these 
two elements close by, showed a significant synergistic effect 
of the promoter activities whereas the BSP promoter which 
does not have RRE and ERE close by in the proximal regions 
of the promoter did not show any cooperative transactivity. It 
is interesting to note that the Opn, Oc, and Alp promoters 
have the RRE and ERE very close by in 10 to 40 bp ranges,and 
also that the binding sites seem to be 10.5, 21, or 31.5 distanc-
es, which is one, two or three rounds of the double-helix DNA 
structure.
Our data demonstrated that MEF and Runx2 have a func-
tional synergistic effect on Opn, Oc, and Alp promoters. How-
ever, we only showed the direct effect of MEF and its cooper-
ativity with Runx2 in the bone marker gene promoters. We 
still cannot tell what the long term effect of MEF is on these 
promoters. That is, if MEF can elevate a transcriptional re-
pressor, the long term effect can be overcome and MEF itself 
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Figure 4.  (A) Bone sialoprotein-luciferase (BSP-Luc) promoter construct was co-transfected with myeloid Elf-1-like factor (MEF) transcrip-
tion factor with or without Runx2 + CBFbeta into COS7 cells. Twenty-four hours after transfection the luciferase activity was measured. In 
BSP-Luc graph, the black bar is for only pCDNA3.1 vector and grey bar is for Runx2 + CBFbeta as expression cDNAs. (B) ROS17/2.8 cells were 
transfected with Mock (pCDNA3.1), MEF, Runx2, or MEF together with Runx2. Runx2 was always introduced with CBFbeta cofactor on the 
mark of ‘Runx2.’ Twenty-four hours after transfection, the cells were harvested, RNA was collected and RT-PCR were performed with Opn 
primers as described in the Materials and Methods.
might have even the opposite effect on bone marker gene 
expression. Thus, the long term effect of MEF needs to be 
further studied.
Opn, a sialic acid-rich phosphoprotein, is a major non-col-
lagenous bone matrix protein and has been suggested to play 
an important role in ossification. Previously, the overlapping 
localization of Opn and Runx2 mRNA, and the marked de-
crease of Opn mRNA expression in Runx2 knockout mice 
have been reported, indicating that the transcription of the 
Opn gene was controlled by Runx2 [23]. It has been also re-
ported that Opn promoter activity was markedly enhanced 
by Runx2 and ETS-1 in a synergistic manner [24]. The syner-
gistic effect was diminished when either the Runx2 or ETS-1 
binding site was mutated. The direct interaction between 
Runx2 and ETS-1 depended on protein-DNA binding. These 
results also suggest that the specific spatial arrangement of 
both sites and direct interaction between Runx2 and ETS-1 
are essential for promoter function. These findings also sup-
port that Runx2 and ETS-1 cooperate to regulate expression 
of the Opn gene.
This promoter is also known to be regulated in carcinogen-
sis. The same RRE and ERE region was also found to be bound 
by Runx2 and ETS-1, although these two factors decreased 
the Opn expression [25]. This difference might be due to the 
different cell context and ETS-1 and MEF characteristics. Also, 
this suppressive result might be due to the delayed time-de-
pendant secondary effect.
In conclusion, our data showed that Runx2 and MEF bind 
nearby on the promoters of the osteoblast markers such as 
Opn, Oc, and Alp and to increase their transcriptional activi-
ties in synergistic manner. Our results also imply that osteo-Journal of Periodontal
& Implant Science JPIS
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blast differentiation and bone formation can be increased by 
activating MEF to elicit the synergistic effect of Runx2 and 
MEF.
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